Publications by authors named "Yazed AlRuthia"

Claim this Profile
D
Driving the future of value-based healthcare in the Gulf Cooperation Council: a roadmap for achieving sustainable access to specialty pharmaceuticals.
Anas Hamad, Ahmed Al-Jedai, Rita Ojeil, Abdulrazaq Sheikh Al-Jazairi, Adel AlAssy, Yazed S AlRuthia

Front Public Health· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling the Financial Burden of Systemic Lupus Erythematosus Management in Saudi Arabia: Insights from a Single-Center Study.
Aseel Alsuwayegh, Yazed AlRuthia

Healthcare (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical and Financial Consequences of Using PCSK9 Inhibitors for Managing Hypercholesterolemia in Saudi Arabia: A Historical Cohort Study.
Yazed AlRuthia, Khlood Khaled Almutairi, Norah Abdulaziz Aljammaz, Aseel Alsuwayegh, Miteb A Alanazi

Healthcare (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing Gabapentinoids' Access Challenges in Saudi Arabia Under New Prescription Regulations: An Expert View.
Khaled K Aldossari, Yazed AlRuthia, Ashraf Amir, Mohammed Alshurem, Hussein Elbadawi

Pain Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Consequence Analysis of Semaglutide vs. Liraglutide for Managing Obese Prediabetic and Diabetic Patients in Saudi Arabia: A Single-Center Study.
Najla Bawazeer, Seham Bin Ganzal, Huda F Al-Hasinah, Yazed Alruthia

Healthcare (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Consequence Analysis of Apixaban Versus Rivaroxaban for Managing Patients with Venous Thromboembolism in Saudi Arabia.
Abdulaali R Almutairi, Yazed Alruthia, Majed S Alyami, Omar A Alshaya, Taif Z Alanazi

Clin Appl Thromb Hemost· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Detection of Type 1 Diabetes in First-Degree Relatives in Saudi Arabia (VISION-T1D): Protocol for a Pilot Implementation Study.
Iman S Algadi, Yazed AlRuthia, Muhammad H Mujammami, Khaled Hani Aburisheh, Metib Alotaibi

JMIR Res Protoc· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare systems and health economics in GCC countries: informing decision-makers from the perspective of the Gulf health economics association.
Yazed AlRuthia, Sara Aldallal, Hana A Al-Abdulkarim, Ahmed Al-Jedai, Hajer Almudaiheem

Front Public Health· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Wasfaty E-Prescribing Platform Against Best Practices for Computerized Provider Order Entry.
Saba Alkathiri, Razan Alothman, Sondus Ata, Yazed Alruthia

Healthcare (Basel)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Direct Medical Costs of Sickle Cell Disease in Saudi Arabia: Insights from a Single Center Study.
Yazed AlRuthia

Healthcare (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness of vedolizumab in advanced therapy-experienced ulcerative colitis patients: Real world data from the Inflammatory Bowel Disease of the Middle East (IBD-ME) Registry group.
Nahla Azzam, Othman Alharbi, Mansour Altuwaijri, Yazed Alruthia, Heba Alfarhan

Saudi J Gastroenterol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and risk factors associated with developing prediabetes in Saudi Arabia.
Ayla M Tourkmani, Turki J Alharbi, Abdulaziz M Bin Rsheed, Azzam F Alotaibi, Mohammed AlEisaa, Yazed AlRuthia

Ann Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget impact analysis of subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in Saudi Arabia: Analysis from payer perspective.
Nimer S Alkhatib, Abdulaali R Almutairi, Majid Almadi, Shiraz Halloush, Yazed Sulaiman H Al-Ruthia

PLoS One· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between self-reported antipsychotics side effects and depression in Saudi Arabia.
Yazed AlRuthia

Saudi Pharm J· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life and Out-of-Pocket Expenditures for Sickle Cell Disease Patients in Saudi Arabia: A Single-Center Study.
Yazed AlRuthia, Rayan B Alanazi, Sultan F Alotaibi, Miteb Alanazi

Healthcare (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valuation of EQ-5D-5L in the Kingdom of Saudi Arabia: A National Representative Study.
Ahmed Al-Jedai, Hajer Almudaiheem, Tareq Al-Salamah, Muath Aldosari, Abdulaali R Almutairi, Yazed AlRuthia

Value Health· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arabic translation and cultural adaptation of Hill-Bone compliance to high blood pressure therapy scale.
Ibrahim Sales, Yazed AlRuthia

Saudi Pharm J· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost consequence analysis of adding semaglutide to treatment regimen for patients with Type II diabetes in Saudi Arabia.
Yazed AlRuthia, Khaled Hani Aburisheh, Sondus Ata, Raghad Bin Salleeh, Shahad B Alqudhibi

Saudi Pharm J· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-consequence analysis of tocilizumab versus adalimumab and etanercept among rheumatoid arthritis patients in Saudi Arabia: a single-center study.
Areej S Albahdal, Amjad M Alotaibi, Miteb A Alanazi, Norah Abanmy, Monira Alwhaibi, Yazed AlRuthia

Cost Eff Resour Alloc· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The socioeconomic burden of spinal muscular atrophy in Saudi Arabia: a cross-sectional pilot study.
Khloud Mubark Alotaibi, Mohannad Alsuhaibani, Khalid S Al-Essa, Ahmed Khamis Bamaga, Amnah S Mukhtar, Yazed AlRuthia

Front Public Health· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effectiveness and cost evaluation of Risankizumab and Adalimumab in the management of psoriasis: a real-world study in Saudi Arabia.
Yazed AlRuthia, Almaha H Alfakhri, Ibtisam Alharbi, Fadi Ali Alghamdi, Miteb A Alanazi

Cost Eff Resour Alloc· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Consequence Analysis of Colon Cancer Screening among Patients with Long-Standing Ulcerative Colitis: 11 Years' Experience of Saudi Population.
Nahla Azzam, Majid Almadi, Mansour Altuwaijiri, Othman Alharbi, Abdulrahman Aljebreen, Yazed Alruthia

Saudi Pharm J· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life of patients with rheumatoid arthritis on tocilizumab, adalimumab, and etanercept in Saudi Arabia: a single-center cross-sectional study.
Amjad M Alotaibi, Areej S Albahdal, Norah Abanmy, Monira Alwhaibi, Yousif Asiri, Yazed AlRuthia

Front Pharmacol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of Procurement and Reimbursement of Pharmaceuticals in Saudi Arabia, United Arab Emirates, Qatar, and Egypt: Challenges and Opportunities.
Anas Hamad, Mai Alsaqa'aby, Yazed Alruthia, Sara Aldallal, Gihan Hamdy Elsisi

Glob J Qual Saf Healthc· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anxiety and depression and health-related quality of life among adults with migraine: a National Population-Based Study.
Monira Alwhaibi, Bander Balkhi, Yazed AlRuthia

Front Public Health· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis